CN1832941A - 作为抗菌剂的卤代喹唑啉基硝基呋喃类化合物 - Google Patents
作为抗菌剂的卤代喹唑啉基硝基呋喃类化合物 Download PDFInfo
- Publication number
- CN1832941A CN1832941A CNA2004800228169A CN200480022816A CN1832941A CN 1832941 A CN1832941 A CN 1832941A CN A2004800228169 A CNA2004800228169 A CN A2004800228169A CN 200480022816 A CN200480022816 A CN 200480022816A CN 1832941 A CN1832941 A CN 1832941A
- Authority
- CN
- China
- Prior art keywords
- compound
- general formula
- nitro
- furyl
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49333603P | 2003-08-08 | 2003-08-08 | |
| US60/493,336 | 2003-08-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1832941A true CN1832941A (zh) | 2006-09-13 |
Family
ID=34135234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2004800228169A Pending CN1832941A (zh) | 2003-08-08 | 2004-08-06 | 作为抗菌剂的卤代喹唑啉基硝基呋喃类化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7410974B2 (enExample) |
| EP (1) | EP1660486A4 (enExample) |
| JP (1) | JP2007501809A (enExample) |
| CN (1) | CN1832941A (enExample) |
| AU (1) | AU2004262533A1 (enExample) |
| BR (1) | BRPI0413372A (enExample) |
| CA (1) | CA2534405A1 (enExample) |
| MX (1) | MXPA06001552A (enExample) |
| WO (1) | WO2005014585A1 (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105796564A (zh) * | 2016-04-12 | 2016-07-27 | 李春 | 一种防治牙体牙髓感染的药物组合物 |
| CN108558854A (zh) * | 2017-06-10 | 2018-09-21 | 曹艳 | 一种治疗革兰氏阳性菌引起的感染的药物及其合成方法 |
| CN108690012A (zh) * | 2017-06-10 | 2018-10-23 | 曹艳 | 一种治疗革兰氏阳性菌引起的感染的药物及其合成方法 |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010016646A1 (en) * | 1998-03-20 | 2001-08-23 | David C. Rueger | Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
| US20080146562A1 (en) * | 2003-08-08 | 2008-06-19 | Ulysses Pharmaceutical Products Inc., | Halogenated quinazolinyl nitrofurans as antibacterial agents |
| US7410974B2 (en) | 2003-08-08 | 2008-08-12 | Ulysses Pharmaceutical Products, Inc. | Halogenated Quinazolinyl nitrofurans as antibacterial agents |
| MX2007003374A (es) * | 2004-09-23 | 2007-06-05 | Ulysses Pharmaceutical Products Inc | Antibioticos carbociclicos y heterociclicos y uso de los mismos. |
| EP2535426A3 (en) | 2006-03-02 | 2013-07-24 | The Uab Research Foundation | Mycobacterial disease detection, treatment, and drug discovery |
| US20110053964A1 (en) * | 2006-08-22 | 2011-03-03 | Roger Tung | 4-aminoquinazoline derivatives and methods of use thereof |
| CN101594870A (zh) * | 2006-08-22 | 2009-12-02 | 康塞特医药品有限公司 | 4-氨基喹唑啉衍生物及其使用方法 |
| WO2008113161A1 (en) * | 2007-03-19 | 2008-09-25 | Ulysses Pharmaceutical Products Inc. | Phosphate prodrugs of quinazolinyl nitrofurans, methods of obtaining, and use of same |
| HUE041512T2 (hu) | 2010-03-30 | 2019-05-28 | Helperby Therapeutics Ltd | Új kombináció és alkalmazás |
| GB201013207D0 (en) | 2010-08-05 | 2010-09-22 | Helperby Therapeutics Ltd | Novel combination |
| JP2013532716A (ja) | 2010-08-05 | 2013-08-19 | ヘルパービー セラピューティクス リミテッド | ピロロキノリン化合物と、β−ラクタム系抗微生物剤、ムピロシンまたはクロルヘキシジンとの組み合わせ |
| GB201015079D0 (en) | 2010-09-10 | 2010-10-27 | Helperby Therapeutics Ltd | Novel use |
| GB201305277D0 (en) | 2013-03-22 | 2013-05-01 | Helperby Therapeutics Ltd | Novel combination and use |
| GB201307989D0 (en) | 2013-05-02 | 2013-06-12 | Helperby Therapeutics Ltd | Novel combinations and use |
| GB201401617D0 (en) | 2014-01-30 | 2014-03-19 | Helperby Therapeutics Ltd | Novel combination and use |
| CN107530397A (zh) | 2014-12-18 | 2018-01-02 | 赫尔普百治疗有限公司 | 新型组合和用途 |
| CN107683136A (zh) | 2015-04-11 | 2018-02-09 | 赫尔普百治疗有限公司 | 口腔组合物 |
| GB201518969D0 (en) | 2015-10-27 | 2015-12-09 | Helperby Therapeutics Ltd | Triple combination |
| GB201610869D0 (en) | 2016-06-22 | 2016-08-03 | Helperby Therapeutics Ltd | Combination |
| GB201612093D0 (en) | 2016-07-12 | 2016-08-24 | Helperby Therapeutics Ltd | Combination |
| GB201616014D0 (en) | 2016-09-20 | 2016-11-02 | Helperby Therapeutics Ltd | Combination |
| GB201616909D0 (en) | 2016-10-05 | 2016-11-16 | Helperby Therapeutics Ltd | Combination |
| GB201703898D0 (en) | 2017-03-10 | 2017-04-26 | Helperby Therapeautics Ltd | Method |
| GB201704620D0 (en) | 2017-03-23 | 2017-05-10 | Helperby Therapeautics Ltd | Combinations |
| GB201709193D0 (en) | 2017-06-09 | 2017-07-26 | Helperby Therapeutics Ltd | Combination |
| GB201807046D0 (en) | 2018-04-30 | 2018-06-13 | Helperby Therapeutics Ltd | Combination |
| GB201913068D0 (en) | 2019-09-10 | 2019-10-23 | Helperby Therapeutics Ltd | Combination |
| GB201914847D0 (en) | 2019-10-14 | 2019-11-27 | Helperby Therapeutics Ltd | Combination |
| GB202213750D0 (en) | 2022-09-20 | 2022-11-02 | Helperby Therapeutics Ltd | Antimicrobial |
| GB202213753D0 (en) | 2022-09-20 | 2022-11-02 | Helperby Therapeutics Ltd | Antimicrobial combinations |
| GB202314387D0 (en) | 2023-09-20 | 2023-11-01 | Helperby Therapeutics Ltd | Antimicrobial combinations |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3324122A (en) * | 1964-12-14 | 1967-06-06 | Norwich Pharma Co | Series of 4-substituted-2-(5-nitro-2-furyl) quinazolines |
| US3542784A (en) * | 1968-04-05 | 1970-11-24 | Norwich Pharma Co | 4-(hydroxyanilino)-2-(5-nitro-2-furyl)quinazolines |
| DE2140280A1 (de) | 1970-08-12 | 1972-02-17 | Chemische Fabrik von Heyden GmbH, 8000 München | 4 Amino 2 eckige Klammer auf 2 (5 Nitro 2 furyl)vinyl eckige Klammer zu chinazolinderivate, Herstellungsver fahren dafür und Arzneimittel daraus |
| US3974277A (en) * | 1974-09-06 | 1976-08-10 | Diamond Shamrock Corporation | 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines as growth promotants and feed efficiency enhancing agents |
| US3973021A (en) * | 1974-09-06 | 1976-08-03 | Diamond Shamrock Corporation | 2-[2-(5-Nitro-2-furyl)vinyl]-4-(phydroxyanilino)quinazoline as a bactericide |
| US3970648A (en) * | 1974-09-06 | 1976-07-20 | Diamond Shamrock Corporation | 2-[2-(5-Nitro-2-furyl)vinyl]-4-(anilino)quinazolines |
| JP2657760B2 (ja) * | 1992-07-15 | 1997-09-24 | 小野薬品工業株式会社 | 4−アミノキナゾリン誘導体およびそれを含有する医薬品 |
| US6148377A (en) * | 1996-11-22 | 2000-11-14 | Mangosoft Corporation | Shared memory computer networks |
| EP0977989A1 (en) | 1997-02-04 | 2000-02-09 | Trega Biosciences, Inc. | 4-substituted-quinoline derivatives and 4-substitute-quinoline combinatorial libraries |
| US5925527A (en) | 1997-02-04 | 1999-07-20 | Trega Biosciences, Inc. | Tricyclic Tetrahydroquinoline derivatives and tricyclic tetrahydroquinoline combinatorial libraries |
| EP0964860B1 (en) * | 1997-02-28 | 2004-04-21 | Pfizer Products Inc. | Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions |
| ATE267817T1 (de) * | 1997-02-28 | 2004-06-15 | Pfizer Prod Inc | Atropisomere von 3-aryl-4(3h)-chinazolinonen und ihre verwendung als ampa-rezeptor |
| US6184377B1 (en) * | 1997-12-15 | 2001-02-06 | Sepracor Inc. | Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof |
| US6943159B1 (en) * | 1998-02-18 | 2005-09-13 | Neurosearch A/S | Compounds and their use as positive AMPA receptor modulators |
| US20020025968A1 (en) * | 1998-04-15 | 2002-02-28 | Rifat Pamukcu | Method for inhibiting neoplastic cells and related conditions by exposure to 4-aminoquinazoline derivatives |
| US20040131628A1 (en) * | 2000-03-08 | 2004-07-08 | Bratzler Robert L. | Nucleic acids for the treatment of disorders associated with microorganisms |
| WO2001081346A2 (en) | 2000-04-25 | 2001-11-01 | Icos Corporation | Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| US6667300B2 (en) * | 2000-04-25 | 2003-12-23 | Icos Corporation | Inhibitors of human phosphatidylinositol 3-kinase delta |
| US6479499B1 (en) * | 2000-06-28 | 2002-11-12 | National Science Council | 2-phenyl-4-quinazolinone compounds, 2-phenyl-4-alkoxy-quinazoline compounds and their pharmaceutical compositions |
| JP4329003B2 (ja) * | 2001-03-23 | 2009-09-09 | バイエル コーポレイション | Rhoキナーゼ阻害剤 |
| US7645878B2 (en) * | 2002-03-22 | 2010-01-12 | Bayer Healthcare Llc | Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof |
| AU2003235956A1 (en) | 2002-04-26 | 2003-11-10 | Nippon Shinyaku Co., Ltd. | Quinazoline derivative and medicine |
| JP2006507352A (ja) | 2002-07-09 | 2006-03-02 | ポイント セラピューティクス, インコーポレイテッド | イソロイシンのボロプロリン化合物に関する方法および組成物 |
| US7410974B2 (en) | 2003-08-08 | 2008-08-12 | Ulysses Pharmaceutical Products, Inc. | Halogenated Quinazolinyl nitrofurans as antibacterial agents |
-
2004
- 2004-08-06 US US10/567,660 patent/US7410974B2/en not_active Expired - Fee Related
- 2004-08-06 EP EP04761630A patent/EP1660486A4/en not_active Withdrawn
- 2004-08-06 CA CA002534405A patent/CA2534405A1/en not_active Abandoned
- 2004-08-06 BR BRPI0413372-2A patent/BRPI0413372A/pt not_active IP Right Cessation
- 2004-08-06 JP JP2006522859A patent/JP2007501809A/ja not_active Withdrawn
- 2004-08-06 AU AU2004262533A patent/AU2004262533A1/en not_active Abandoned
- 2004-08-06 CN CNA2004800228169A patent/CN1832941A/zh active Pending
- 2004-08-06 WO PCT/CA2004/001466 patent/WO2005014585A1/en not_active Ceased
- 2004-08-06 MX MXPA06001552A patent/MXPA06001552A/es not_active Application Discontinuation
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105796564A (zh) * | 2016-04-12 | 2016-07-27 | 李春 | 一种防治牙体牙髓感染的药物组合物 |
| CN108558854A (zh) * | 2017-06-10 | 2018-09-21 | 曹艳 | 一种治疗革兰氏阳性菌引起的感染的药物及其合成方法 |
| CN108690012A (zh) * | 2017-06-10 | 2018-10-23 | 曹艳 | 一种治疗革兰氏阳性菌引起的感染的药物及其合成方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06001552A (es) | 2006-09-04 |
| WO2005014585A1 (en) | 2005-02-17 |
| BRPI0413372A (pt) | 2006-10-17 |
| JP2007501809A (ja) | 2007-02-01 |
| US7410974B2 (en) | 2008-08-12 |
| EP1660486A4 (en) | 2006-12-13 |
| US20060258693A1 (en) | 2006-11-16 |
| AU2004262533A1 (en) | 2005-02-17 |
| WO2005014585A8 (en) | 2005-09-09 |
| CA2534405A1 (en) | 2005-02-17 |
| EP1660486A1 (en) | 2006-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1832941A (zh) | 作为抗菌剂的卤代喹唑啉基硝基呋喃类化合物 | |
| CN1073112C (zh) | 任选取代的8-氰基-1-环丙基-7-(2,8-二氮杂双环[4.3.0]壬-8-基)-6-氟-1,4-二氢-4-氧代-3-喹啉羧酸及其衍生物 | |
| CN1035945C (zh) | 5-烷基喹诺酮羧酸衍生物的制备方法 | |
| CN1481368A (zh) | 促旋酶抑制剂和其用途 | |
| CN1067999C (zh) | 抗螺杆菌的唑酮类杂环衍生物 | |
| CN1250291C (zh) | 含有抗生素和祛痰药的稳定药物组合物及其制备方法 | |
| CN1183115C (zh) | 5-氨基-8-甲氧基喹诺酮羧酸类衍生物及其制法 | |
| CN101027299A (zh) | 碳-和杂-环硝基呋喃抗生素及其应用 | |
| CN1212317C (zh) | 新颖的酯或酰胺衍生物 | |
| CN1116301C (zh) | 四环氟喹诺酮羧酸,其制备方法及其为活性成份的药物组合物 | |
| US20080146562A1 (en) | Halogenated quinazolinyl nitrofurans as antibacterial agents | |
| CN1157389C (zh) | 喹啉羧酸衍生物或其盐 | |
| CN1763018A (zh) | 噁唑烷酮类化合物 | |
| CN1764450A (zh) | 结晶型n-甲酰基羟胺化合物 | |
| CN1662240A (zh) | 苯基噁唑烷酮衍生物 | |
| CN1290834C (zh) | 喹啉衍生物和它们作为抗生素的用途 | |
| US8217172B2 (en) | Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea | |
| CN1116300C (zh) | 四环氟喹诺酮羧酸,其制备方法及其为活性成份的药物组合物 | |
| CN1190439C (zh) | 四环氟喹诺酮羧酸,其制备方法及其为活性成份的药物组合物 | |
| HK1108285A (en) | Carbo- and hetero-cyclic antibiotics and use thereof | |
| CN1152019C (zh) | 具有杀菌活性的2-(4-甲硫苯氧基)咪唑啉酮衍生物及其制备方法 | |
| CN1114319A (zh) | 1,9-桥连的噻唑并[3,2-a]喹啉衍生物 | |
| CN1425669A (zh) | 四环氟喹诺酮羧酸,其制备方法及其为活性成份的药物组合物 | |
| CN1097750A (zh) | 5-氨基喹诺酮羧酸衍生物及其含有该衍生物作为活性成分的抗菌剂 | |
| Shrestha et al. | Antibacterial Activity Evaluation of Some Synthesized 1, 2 Disubstituted Benzimidazole Derivatives along with Beta Lactum Benzimidazole Derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |